Dynamics of antimicrobial resistance and virulence of Salmonella enterica serovar Dublin

Reviewer #1 (Public review):

The manuscript consists of two separate but interlinked investigations: genomic epidemiology and virulence assessment of Salmonella Dublin. ST10 dominates the epidemiological landscape of S. Dublin, while ST74 was uncommonly isolated. Detailed genomic epidemiology of ST10 unfolded the evolutionary history of this common genotype, highlighting clonal expansions linked to each distinct geography. Notably, North American ST10 was associated with more antimicrobial resistance compared to others. The authors also performed long-read sequencing on a subset of isolates (ST10 and ST74) and uncovered a novel recombinant virulence plasmid in ST10 (IncX1/IncFII/IncN). Separately, the authors performed cell invasion and cytotoxicity assays on the two S. Dublin genotypes, showing differential responses between the two STs. ST74 replicates better intracellularly in macrophages compared to ST10, but both STs induced comparable cytotoxicity levels. Comparative genomic analyses between the two genotypes showed certain genetic content unique to each genotype, but no further analyses were conducted to investigate which genetic factors were likely associated with the observed differences. The study provides a comprehensive and novel understanding of the evolution and adaptation of two S. Dublin genotypes, which can inform public health measures.

The methodology included in both approaches was sound and written in sufficient detail, and data analysis was performed with rigour. Source data were fully presented and accessible to readers. Certain aspects of the manuscript could be clarified and extended to improve the manuscript.

(1) For epidemiology purposes, it is not clear which human diseases were associated with the genomes included in this manuscript. This is important since S. Dublin can cause invasive bloodstream infections in humans. While such information may be unavailable for public sequences, this should be detailed for the 53 isolates sequenced for this study, especially for isolates selected to perform experiments in vitro.

(2) The major AMR plasmid in described S. Dublin was the IncC associated with clonal expansion in North America. While this plasmid is not found in the Australian isolates sequenced in this study, the reviewer finds that it is still important to include its characterization, since it carries blaCMY-2 and was sustainedly inherited in ST10 clade 5. If the plasmid structure is already published, the authors should include the accession number in the Main Results.

(3) The reviewer is concerned that the multiple annotations missing in
(a) plasmid structures in Supplementary Figures 5 & 6, and
(b) genetic content unique to ST10 and ST74 was due to insufficient annotation by Prokka. I would recommend the authors use another annotation tool, such as Bakta (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743544/) for plasmid annotation, and reconstruction of the pangenome described in Supplementary Figure 10. Since the recombinant virulence plasmid in ST10 is a novel one, I would recommend putting Supplementary Figure 5 as a main figure, with better annotations to show the virulence region, plasmid maintenance/replication, and possible conjugation cluster.

(4) The authors are lauded for the use of multiple strains of ST10 and ST74 in the in vitro experiment. While results for ST74 were more consistent, readouts from ST10 were more heterogenous (Figure 5, 6). This is interesting as the tested ST10 were mostly clade 1, so ST10 was, as expected, of lower genetic diversity compared to tested ST74 (partly shown in Figure 1D. Could the authors confirm this by constructing an SNP table separately for tested ST10 and ST74? Additionally, the tested ST10 did not represent the phylogenetic diversity of the global epidemiology, and this limitation should be reflected in the Discussion.

(5) The comparative genomics between ST10 and ST74 can be further improved to allow more interpretation of the experiments. Why were only SPI-1, 2, 6, and 19 included in the search for virulome, how about other SPIs? ST74 lacks SPI-19 and has truncated SPI-6, so what would explain the larger genome size of ST74? Have the authors screened for other SPIs using more well-annotated databases or references (S. Typhi CT18 or S. Typhimurium ST313)? The mismatching between in silico prediction of invasiveness and phenotypes also warrants a brief discussion, perhaps linked to bigger ST74 genome size (as intracellular lifestyle is usually linked with genome degradation).

(6) On the epidemiology scale, ST10 is more successful, perhaps due to its ongoing adaptation to replication inside GI epithelial cells, favouring shedding. ST74 may tend to cause more invasive disease and less transmission via fecal shedding. The presence of T6SS in ST10 also can benefit its competition with other gut commensals, overcoming gut colonization resistance. The reviewer thinks that these details should be more clearly rephrased in the Discussion, as the results highly suggested different adaptations of two genotypes of the same serovar, leading to different epidemiological success.

Reviewer #2 (Public review):

This is a comprehensive analysis of Salmonella Dublin genomes that offers insights into the global spread of this pathogen and region-specific traits that are important to understanding its evolution. The phenotyping of isolates of ST10 and ST74 also offers insights into the variability that can be seen in S. Dublin, which is also seen in other Salmonella serovars, and reminds the field that it is important to look beyond lab-adapted strains to truly understand these pathogens. This is a valuable contribution to the field. The only limitation, which the authors also acknowledge, is the bias towards S. Dublin genomes from high-income settings. However, there is no selection bias; this is simply a consequence of publically available sequences.